SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CUNEO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.062
AS - Asia 13.409
EU - Europa 9.115
SA - Sud America 2.526
AF - Africa 186
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 14
AN - Antartide 1
Totale 54.333
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.493
SG - Singapore 4.860
CN - Cina 4.276
BR - Brasile 2.208
DE - Germania 2.028
UA - Ucraina 1.739
HK - Hong Kong 1.578
IT - Italia 1.392
TR - Turchia 1.225
GB - Regno Unito 903
FI - Finlandia 709
VN - Vietnam 658
RU - Federazione Russa 572
PL - Polonia 468
SE - Svezia 460
MX - Messico 287
FR - Francia 271
ID - Indonesia 243
CA - Canada 224
IN - India 158
AR - Argentina 121
NL - Olanda 106
ZA - Sudafrica 103
BD - Bangladesh 94
CZ - Repubblica Ceca 90
BE - Belgio 89
JP - Giappone 88
ES - Italia 73
EC - Ecuador 70
AT - Austria 64
LT - Lituania 50
IQ - Iraq 40
PK - Pakistan 27
PY - Paraguay 26
MA - Marocco 25
UZ - Uzbekistan 24
CO - Colombia 21
VE - Venezuela 21
CL - Cile 20
AE - Emirati Arabi Uniti 18
PE - Perù 17
IL - Israele 16
AU - Australia 15
CH - Svizzera 14
RO - Romania 14
DO - Repubblica Dominicana 13
IE - Irlanda 13
KE - Kenya 13
KR - Corea 13
IR - Iran 12
EG - Egitto 10
EU - Europa 10
JO - Giordania 10
SA - Arabia Saudita 10
TN - Tunisia 10
BO - Bolivia 9
JM - Giamaica 9
UY - Uruguay 9
AZ - Azerbaigian 8
BG - Bulgaria 8
DZ - Algeria 7
LV - Lettonia 7
TT - Trinidad e Tobago 7
PH - Filippine 6
AL - Albania 5
BB - Barbados 5
BY - Bielorussia 5
CR - Costa Rica 5
HN - Honduras 5
HU - Ungheria 5
KZ - Kazakistan 5
NP - Nepal 5
OM - Oman 5
PA - Panama 5
BH - Bahrain 4
HR - Croazia 4
MY - Malesia 4
NZ - Nuova Zelanda 4
RS - Serbia 4
SI - Slovenia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CI - Costa d'Avorio 3
DK - Danimarca 3
KG - Kirghizistan 3
LB - Libano 3
MK - Macedonia 3
NG - Nigeria 3
PS - Palestinian Territory 3
PT - Portogallo 3
SN - Senegal 3
TW - Taiwan 3
AM - Armenia 2
BW - Botswana 2
EE - Estonia 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
GF - Guiana Francese 2
GT - Guatemala 2
LK - Sri Lanka 2
Totale 54.307
Salva come PNG Salva come JPEG
Città #
Fairfield 3.016
Woodbridge 2.968
Singapore 2.576
Ashburn 2.449
Houston 2.031
Jacksonville 1.862
Chandler 1.677
Hong Kong 1.574
Beijing 1.481
Ann Arbor 1.362
Santa Clara 1.344
Seattle 1.175
Wilmington 1.131
Cambridge 976
Izmir 647
Nanjing 592
Dallas 492
Munich 482
Princeton 480
Warsaw 449
Los Angeles 448
New York 397
San Diego 311
Boardman 309
Ferrara 279
Milan 239
São Paulo 217
Shanghai 210
Ho Chi Minh City 204
Mexico City 204
Jakarta 199
Shenyang 188
Nanchang 172
Turku 171
Helsinki 151
Dong Ket 132
Hebei 128
Bremen 115
Addison 113
Hanoi 113
Hefei 113
London 112
Tianjin 112
Chicago 108
Buffalo 104
Changsha 100
Falls Church 88
Jiaxing 88
Brussels 86
Moscow 86
Dearborn 83
Montreal 79
Tokyo 79
Rio de Janeiro 78
Brooklyn 75
Jinan 73
Toronto 71
Mountain View 69
Zhengzhou 67
Redwood City 63
Stockholm 63
Chennai 61
Falkenstein 59
San Francisco 59
Johannesburg 56
Norwalk 55
Phoenix 54
Denver 53
Brno 50
Rome 49
Brasília 48
Belo Horizonte 47
Kunming 46
Nuremberg 46
Poplar 46
San Mateo 46
Bologna 45
Frankfurt am Main 45
Atlanta 42
Orem 41
Boston 40
Guangzhou 40
Ningbo 40
The Dalles 39
Manchester 38
Curitiba 36
Olomouc 34
Orange 34
Lappeenranta 33
Washington 30
Columbus 29
Des Moines 29
Hangzhou 29
Vienna 29
Auburn Hills 27
Campinas 27
Haiphong 27
Ankara 26
Quito 26
Verona 26
Totale 36.448
Salva come PNG Salva come JPEG
Nome #
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 359
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 251
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 247
CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis 236
Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation 228
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 228
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 228
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 227
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 223
5' region and exon 7 mutations of the TP53 gene in two cases of B-cell prolymphocytic leukemia 221
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 221
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 220
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 218
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia. 216
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 215
Acute Human Herpesvirus-6A infection of human mesothelial cells modulates HLA molecules 210
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 210
A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs 209
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 208
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 207
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells 206
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 205
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 205
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 205
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 204
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 203
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 203
A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma 203
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 203
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 202
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 201
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 197
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 195
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype 195
Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML 193
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 190
MORFOLOGIA E FISIOPATOLOGIA DEL SANGUE E DEGLI ORGANI EMOPOIETICI 188
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 187
Secondary chromosome changes in mantle cell lymphoma: Cytogenetic and fluorescence in situ hybridization studies 186
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 185
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 185
Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: Comparison with metaphase banding analysis 184
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 184
Novel small deletions of the p53 gene in late stage B-cell chronic lymphocytic leukaemia 183
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 182
Exposure to myelotoxic agents and myelodysplasia: Case-control study and correlation with clinicobiological findings 182
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells 181
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype 180
Delirium in acute promyelocytic leukemia patients: Two case reports 180
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 180
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 179
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 179
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 178
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 178
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 177
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells from different sources. Evidence of discordant reactivity for various immunological markers 177
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 173
Differentiation of follicular dendritic sarcoma cells into functional myeloiddendritic cell-like elements 173
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 172
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 172
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 170
B-Cell chronic lymphocytic leukemia (B-CLL) with 14q32 translocations: haematological features and clinical outcome. 169
[Use of 5-phosphodiesterase inhibitors in patients with LUTS secondary to BPH: our experience and review of the literature]. 169
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 169
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 168
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 167
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia 166
Alterazioni cromosomiche in cellule staminali emopoietiche indotte da esposizioni ambientali o professionali. 166
Dendritic cells in acute promyelocytic leukaemia 166
A novel translocation t(1;7)(p36;q34) in three patients with acute myeloid leukaemia 166
Minimal morphological criteria for defining bone marrow dysplasia: A basis for clinical implementation of WHO classification of myelodysplastic syndromes 166
A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients 166
Detection of inherited chromosomally integrated HHV-6 (ciHHV-6) in a marker chromosome 165
Four novel non-random chromosome rearrangements in B-cell chronic lymphocytic leukaemia: 6p24-25 and 12p12-13 translocations, 4q21 anomalies and monosomy 21 165
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 164
Tryptase-positive mast cells predict clinical outcome of patients with early B-cell chronic lymphocytic leukemia 164
Hepatosplenic T-cell lymphoma (HSTCL). 163
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 162
Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation 161
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 160
Exercise training and endothelial progenitor cells in haemodialysis patients 160
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: Correlations with aetiological and clinical-biological findings 160
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 159
Therapy-related adult acute lymphoblastic leukemia with t(4;11)(q21;q23): MLL rearrangement, p53 mutation and multilineage involvement 159
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis 158
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 158
Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: Cytologic and cytogenetic evidence in thirty-four patients 157
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 157
Waldenstrom macroglobulinemia 156
Ibrutinib in the real world patient: Many lights and some shades 155
Mobilization of endothelial progenitor cells in patientes with haematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation 155
Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with granulocyte colony stimulating factor and chemotherapy for autologous transplantation 154
Cytogenetic and clinicobiological features of acute leukemia with stem cell phenotype: study of nine cases 153
Molecular cytogenetic characterization of marginal zone B-cell lymphoma: correlation with clinicopathologic findings in 14 cases 153
Atypical chronic lymphocytic leukaemia with t(11;14)(q13;q32): karyotype evolution and prolymphocytic transformation 153
Myelofibrosis with Myeloid Metaplasia (MMM)/Idiopathic myelofibrosis/Agnogenic myeloid metaplasia 152
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 151
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib 150
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 150
Cytogenetic and molecular cytogenetic characterization of 6 new cases of idiopathic hypereosinophilic syndrome 149
Totale 18.528
Salva come PNG Salva come JPEG
Categoria #
all - tutte 279.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 33.894
Totale 313.648
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.894 0 0 0 0 275 620 206 639 109 802 779 464
2021/20224.235 230 531 203 195 226 230 230 260 138 359 427 1.206
2022/20234.073 500 178 138 464 698 594 181 363 560 21 250 126
2023/20242.042 186 284 97 50 128 283 89 111 65 55 79 615
2024/20259.403 315 200 787 324 1.145 746 242 510 1.537 1.225 1.265 1.107
2025/202611.917 2.382 1.385 2.438 3.786 1.926 0 0 0 0 0 0 0
Totale 55.103